Dow Jones Top Company Headlines at 5 AM ET: GSK to Buy Nuvalent for $10.6 Billion in Oncology Push | University ...

GSK Makes Its Biggest Bet In More Than A Decade, Paying $10.6 Billion For Cancer Drug Developer Nuvalent

GSK will acquire Nuvalent for $10.6 billion to expand its lung cancer pipeline as Nuvalent shares surge nearly 39%.